You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AG-120

Showing 1 - 25 of 3,428
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Acute Myeloid Leukemia Trial in New Haven (AG-120, Nivolumab)

Withdrawn
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • New Haven, Connecticut
    Yale Cancer Center
Jan 6, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • AG-120
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Advanced Solid Tumor, IDH1 Mutation, Glioma Trial in Pittsburgh (ivosidenib and nivolumab)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • ivosidenib and nivolumab
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 14, 2022

Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma Trial in Worldwide (AG-120, Placebo)

Completed
Has Results
  • Advanced Cholangiocarcinoma
  • Metastatic Cholangiocarcinoma
  • AG-120
  • Placebo
  • Scottsdale, Arizona
  • +48 more
Dec 20, 2022

Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

Recruiting
  • Acute Myeloid Leukemia
  • Decitabine and Cedazuridine
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Unresectable Cholangiocarcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Cholangiocarcinoma
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Jun 24, 2022

Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Biopsy, Enasidenib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jun 30, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • AG-120
  • +2 more
  • Duarte, California
  • +72 more
Aug 18, 2022

Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2021

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • +4 more
  • Rochester, New York
  • +1 more
Oct 28, 2021

Malaria,Falciparum, Malaria in Pregnancy, Malaria in Childbirth Trial in Kinshasa, Eldoret (Malaria High-Sensitivity Rapid

Not yet recruiting
  • Malaria,Falciparum
  • +8 more
  • Malaria High-Sensitivity Rapid Diagnostic Test (HS-RDT)
  • Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
  • Kinshasa, Congo, The Democratic Republic of the
  • +1 more
Feb 24, 2023

Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

Recruiting
  • Previously Untreated Acute Myeloid Leukemia
  • Samalizumab (BAML-16-001-S1)
  • +32 more
  • Phoenix, Arizona
  • +18 more
Oct 17, 2022

Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Recurrent Myeloproliferative Tumor Trial in Chicago

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • +4 more
  • Chicago, Illinois
    Northwestern University
Mar 26, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (AG-120, Placebo for AG-120, AG-221)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • AG-120
  • +3 more
  • Adelaide, Australia
  • +181 more
Aug 31, 2021

Motor Function, Cognitive Function, Contrast Media Trial in Worldwide (Motor Tests, Cognitive Tests, Unenhanced-MRI of the

Recruiting
  • Motor Function
  • +2 more
  • Motor Tests
  • +9 more
  • Scottsdale, Arizona
  • +31 more
Feb 21, 2022

Leukemia, Myeloid, Isocitrate Dehydrogenase Trial in Worldwide (AG-221, BSC, Azacitidine)

Active, not recruiting
  • Leukemia, Myeloid
  • Isocitrate Dehydrogenase
  • Los Angeles, California
  • +145 more
Jun 7, 2022

This is a Phase Study Conducted in Healthy Volunteers, Osteoporosis Trial (Denosumab)

Not yet recruiting
  • This is a Phase Study Conducted in Healthy Volunteers
  • Osteoporosis
  • Denosumab
  • (no location specified)
May 17, 2023

Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Puerto Rico, United States (Ivosidenib)

Recruiting
  • Recurrent Ependymoma
  • +32 more
  • Birmingham, Alabama
  • +173 more
Jan 27, 2023

Cannabis, THC Trial (?9-tetrahydrocannabinol)

Not yet recruiting
  • Cannabis
  • THC
  • (no location specified)
Oct 23, 2023

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Oral rucaparib)

Completed
Has Results
  • Ovarian Cancer
  • +3 more
  • Oral rucaparib
  • Anchorage, Alaska
  • +74 more
Jan 31, 2022

Self-efficacy and Well-being of Fibrotic Interstitial Lung

Not yet recruiting
  • Interstitial Lung Disease
  • +5 more
  • inpatient rehabilitation
  • Bern, Heiligenschwendi, Switzerland
  • +1 more
Aug 31, 2023

Eating Behavior, Obesity, Appetitive Behavior Trial in London (0 kcal liquid, 600 kcal liquid meal, 1200 kcal liquid meal)

Recruiting
  • Eating Behavior
  • +2 more
  • 0 kcal liquid
  • +3 more
  • London, United Kingdom
    PsychoNeuroEndocrinology Research Group, Division of Psychiatry,
Aug 29, 2023

HIV, HIV Seronegativity Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • HIV Seronegativity
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +1 more
Oct 28, 2021